Rick Berke
Showing 1–7 of 7 transcripts.
- Milken Institute56 min
Chronic Disease: Exacerbating the Pandemic
Rick Berke, Susan Bailey, Garth Graham, Jaana Remes, Brooks Tingle
A high-level panel convened by the American Medical Association addresses a dual crisis where the COVID-19 pandemic has exacerbated chronic disease management and highlighted severe racial health disparities. Industry leaders from CVS Health, John Hancock, and academia propose systemic reforms including the "Time for Care" initiative, insurance models that actively incentivize preventative behaviors, and the urgent need for disaggregated health data to dismantle structural inequities. The discussion emphasizes a permanent shift toward telemedicine and consumer empowerment strategies designed to reverse dangerous trends in delayed medical care while framing public health investment as a critical driver of global economic recovery.
- Milken Institute21 min
Public Health Response to the Coronavirus
Dr. Christopher Morris of George Washington University assesses the early trajectory of the novel coronavirus outbreak, noting over 45,000 confirmed cases and 1,100 deaths while questioning the transparency of Chinese data reporting. He identifies two primary outcomes: the virus either becoming a severe seasonal pathogen or triggering a global pandemic, a scenario compounded by a lack of sustained funding for coronavirus research. Morris further highlights the WHO's enforcement delays and the urgent need for rapid diagnostic technologies, as vaccine development remains a minimum one-year process.
- Milken Institute1h 0m
New Pathways to Neuroscience Breakthroughs
Rick Berke, Cara Altimus, Jeffrey Borenstein, Niranjan Bose, Johannes Streffer, Mike Belville, David Mongeau, Janet Knupp, Jing Lu, Ian Kramer, Anna McAllister
A panel of experts highlighted the critical gap in preventing and treating brain disorders despite projections that dementia cases will double over the next three decades. To address historical stagnation and corporate retreat, the discussion emphasized a strategic pivot toward diverse biological hypotheses, early biomarker detection, and philanthropic de-risking led by organizations like the Gates Foundation. This approach aims to overcome diagnostic delays and therapeutic failures by integrating real-world data, stem cell modeling, and patient-centric outcomes to accelerate the development of rapid-acting treatments.
- Milken Institute29 min
Mic'd Up - Part 2:Genomics & the Future of Medicine
Rick Berke, Phil Febbo, Anamika Mehta, Rakesh Suri
The event details how advanced viral defense mechanisms, culturally attuned facility designs, and rapidly declining genomic sequencing costs are reshaping clinical precision medicine, with specific case studies highlighting Cleveland Clinic Abu Dhabi's successful integration of these technologies. Key speakers analyze the friction caused by fragmented U.S. payers and electronic health records while contrasting these challenges with the streamlined adoption seen in the UK and the UAE's population-specific cancer initiatives. The discussion concludes with a strategic roadmap for the next decade that emphasizes decentralized care, robust data privacy protocols, and AI-driven analytics to transform genomic insights into actionable, personalized patient outcomes.
- Milken Institute25 min
Mic'd Up - Part 1: Public Health Response to Coronavirus
This expert panel discusses the emerging COVID-19 outbreak, noting its official WHO naming to prevent stigmatization, approximately 45,000 confirmed cases primarily in China, and the critical lack of international access due to data transparency concerns. Speakers analyze divergent future scenarios ranging from endemic circulation to a global pandemic with a 2% fatality rate, while critiquing delayed WHO leadership and insufficient vaccine development timelines that may exceed a year. The discussion further addresses necessary public health strategies, including social distancing over universal masking, the economic risks of draconian travel restrictions, and the urgent need for rapid diagnostic deployment amid funding cycles that previously hampered preparedness.
- Milken Institute27 min
CDC Director Robert Redfield: 'Opioid Epidemic is the public health crisis of our time'
This event details a strategic review of an organization facing significant funding uncertainties and access barriers while pivoting toward social justice, independent scientific research, and multi-year capital market transitions. Key figures addressed the contradiction between current resource limitations and plans to expand operations through federal partnerships over a projected three-year timeline to better manage global crises. Despite ambiguous historical anchors and disjointed narrative segments, the discussion concluded with a commitment to advancing systemic reforms and developing spiritual leadership capabilities among students.
- Milken Institute59 min
Artificial Intelligence and Machine Learning in Medicine: Hope or Hype?
Rick Berke, Rowan Chapman, Iya Khalil, Lloyd Minor, George Yancopoulos, Megan Zweig, Dan Furstenberg
Industry leaders and researchers convened to address the critical bottleneck of poor data quality in healthcare AI, noting that high-quality "big data" is essential for overcoming the limitations of existing Electronic Health Records and avoiding failures like those seen with IBM Watson. While venture capital has pivoted from high-risk clinical decision support to near-term applications in operational efficiency and medical imaging, participants advocated for long-term systemic reforms such as FDA mandates for molecular data collection and a $200 million biobank initiative to enable precise patient phenotyping. The panel concluded that bridging the gap between clinical trial success and real-world outcomes requires rigorous regulatory frameworks and collaborative investment to reduce physician burnout and improve drug development success rates.